Literature DB >> 16170650

PEN-2 gene mutation in a familial Alzheimer's disease case.

C Sala Frigerio1, P Piscopo, E Calabrese, A Crestini, L Malvezzi Campeggi, R Civita di Fava, S Fogliarino, D Albani, G Marcon, R Cherchi, R Piras, G Forloni, A Confaloni.   

Abstract

Genetic evidence indicates a central role of cerebral accumulation of beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD). Beside presenilin 1 and 2, three other recently discovered proteins (Aph 1, PEN 2 and nicastrin) are associated with gamma-secretase activity, the enzymatic complex generating Abeta. Alterations in genes encoding these proteins were candidates for a role in AD. The PEN 2 gene was examined for unknown mutations and polymorphisms in sporadic and familial Alzheimer patients. Samples from age-matched controls (n=253), sporadic AD (SAD, n=256) and familial AD (FAD, n=140) were screened with DHPLC methodology followed by sequencing. Scanning the gene identified for the first time a missense mutation (D90N) in a patient with FAD. Three intronic polymorphisms were also identified, one of which had a higher presence of the mutated allele in AD subjects carrying the allele epsilon4 of apolipoprotein E than controls. The pathogenic role of the PEN-2 D90N mutation in AD is not clear, but the findings might lead to new studies on its functional and genetic role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170650     DOI: 10.1007/s00415-005-0799-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis.

Authors:  A C Jones; J Austin; N Hansen; B Hoogendoorn; P J Oefner; J P Cheadle; M C O'Donovan
Journal:  Clin Chem       Date:  1999-08       Impact factor: 8.327

2.  Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila.

Authors:  H M Chung; G Struhl
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

Review 3.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

4.  No replication of the association between the Nicastrin gene and familial early-onset Alzheimer's disease.

Authors:  Emmanuelle Cousin; Didier Hannequin; Sandrine Macé; Bruno Dubois; Sylvain Ricard; Emmanuelle Génin; Christophe Brun; Céline Chansac; Laurent Pradier; Thierry Frebourg; Alexis Brice; Dominique Campion; Jean-François Deleuze
Journal:  Neurosci Lett       Date:  2003-12-19       Impact factor: 3.046

5.  Membrane topology of gamma-secretase component PEN-2.

Authors:  Adam S Crystal; Vanessa A Morais; Theodore C Pierson; Donald S Pijak; Dan Carlin; Virginia M-Y Lee; Robert W Doms
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

6.  The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample.

Authors:  Bart Dermaut; Jessie Theuns; Kristel Sleegers; Hiroshi Hasegawa; Marleen Van den Broeck; Krist'l Vennekens; Ellen Corsmit; Peter St George-Hyslop; Marc Cruts; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2002-04-24       Impact factor: 11.025

7.  PEN2 is not a genetic risk factor for Alzheimer's disease in a large family sample.

Authors:  L Bertram; R Menon; K Mullin; M Parkinson; M L Bradley; D Blacker; R E Tanzi
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

Review 8.  Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.

Authors:  Gianluigi Forloni; Liana Terreni; Ilaria Bertani; Sergio Fogliarino; Roberto Invernizzi; Andrea Assini; Giuseppe Ribizzi; Alessandro Negro; Elena Calabrese; Maria Antonietta Volonté; Claudio Mariani; Massimo Franceschi; Massimo Tabaton; Alessandro Bertoli
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

9.  Nicastrin gene in familial and sporadic Alzheimer's disease.

Authors:  Annamaria Confaloni; Liana Terreni; Paola Piscopo; Alessio Crestini; Lorenzo Malvezzi Campeggi; Carlo Sala Frigerio; Ida Blotta; Maria Perri; Manuela Di Natale; Raffaele Maletta; Gabriella Marcon; Massimo Franceschi; Amalia C Bruni; Gianluigi Forloni; Alfredo Cantafora
Journal:  Neurosci Lett       Date:  2003-12-15       Impact factor: 3.046

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  3 in total

Review 1.  The genetics of Alzheimer disease.

Authors:  Rudolph E Tanzi
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

2.  Structural and Functional Determinants of gamma-Secretase, an Intramembrane Protease Implicated in Alzheimer's Disease.

Authors:  Patrick C Fraering
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

3.  Neuron-specific deletion of presenilin enhancer2 causes progressive astrogliosis and age-related neurodegeneration in the cortex independent of the Notch signaling.

Authors:  Hui-Ru Bi; Cui-Hua Zhou; Yi-Zhi Zhang; Xu-Dong Cai; Mu-Huo Ji; Jian-Jun Yang; Gui-Quan Chen; Yi-Min Hu
Journal:  CNS Neurosci Ther       Date:  2020-09-22       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.